Related Experiment Video
Updated: Aug 4, 2026

Normothermic Negative Pressure Ventilation Ex Situ Lung Perfusion: Evaluation of Lung Function and Metabolism
Published on: February 14, 2022
Extracorporeal life support in pertussis
Suneel Pooboni1, Neil Roberts, Claire Westrope
1Department of Extracorporeal Membrane Oxygenation and Paediatric Intensive Care, Glenfield Hospital, Groby Road, Leicester LE3 9PQ, UK.
Insights
Severe pertussis (whooping cough) in infants can be fatal. Extracorporeal membrane oxygenation (ECMO) offers a potential treatment for respiratory failure, but mortality remains high, especially with multi-organ dysfunction.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe B. pertussis (pertussis) infection presents with respiratory failure, pulmonary hypertension, and leukocytosis in infants.
- Unvaccinated infants under 3 months are particularly vulnerable to severe pertussis complications.
Purpose of the Study:
- To analyze the course and outcomes of severe B. pertussis infection treated with extracorporeal membrane oxygenation (ECMO).
- To evaluate the efficacy and identify factors associated with mortality in infants receiving ECMO for pertussis.
Main Methods:
- Retrospective case analysis of infants treated with ECMO for severe B. pertussis infection over a decade.
- Review of clinical data including age, vaccination status, neutrophil count, and organ dysfunction.
Main Results:
- Out of 12 infants receiving ECMO for pertussis, 7 (58%) died.
- High mortality was linked to elevated neutrophil counts and multi-organ dysfunction (pulmonary hypertension, hypotension, renal insufficiency, seizures).
- All treated infants were unvaccinated and under 3 months old.
Conclusions:
- ECMO is a viable option for infants with pertussis-related respiratory failure unresponsive to mechanical ventilation.
- Further research is needed to optimize ECMO management for infants with severe pertussis and multi-organ dysfunction.
Abstract:
Severe B. pertussis infection in infants is characterized by severe respiratory failure, pulmonary hypertension, leukocytosis, and death. This retrospective case analysis highlights the course and outcome of severe B. pertussis infection treated with extracorporeal membrane oxygenation (ECMO) at a single center. Over the last decade, out of a total caseload of nearly 800 infants and children, 12 infants with severe B. pertussis have been referred for ECMO therapy to our center. All infants with pertussis infection who received ECMO therapy were less than 3 months of age at presentation and unvaccinated. There was a high mortality rate (7 of 12 infants died), which was associated with an elevated neutrophil count at presentation and multiorgan dysfunction characterized by intractable pulmonary hypertension, persistent systemic hypotension, renal insufficiency, and fits. ECMO should be offered to children with pertussis infection and respiratory failure refractory to mechanical ventilation. However, further research is required to determine the optimal management for infants receiving ECMO therapy with this disease.
More Related Videos
Related Concept Videos
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-III
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Cardiopulmonary Resuscitation II: ACLS Airway Management

